Latanoprost Zentiva

Latanoprost, the active ingredient in Latanoprost Zentiva, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It works by increasing uveoscleral outflow of aqueous humor, thereby reducing intraocular pressure in patients diagnosed with open‑angle glaucoma or ocular hypertension.

GNH USA supplies Latanoprost Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide, ensuring quality, regulatory conformity and a robust supply chain across markets with consistent batch‑to‑batch consistency and compliance with EU pharmacopeial standards.

Latanoprost is indicated for conditions affecting intraocular pressure within the glaucoma and ocular hypertension disease family. - Open‑angle glaucoma: lowers intraocular pressure to slow visual field loss. - Ocular hypertension: reduces elevated eye pressure to prevent progression to glaucoma. - Prevention of disease progression in glaucoma patients: maintains target pressure to limit optic nerve damage.

Latanoprost may cause ocular and systemic reactions.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Iris color change: gradual darkening of the iris. - Eye irritation: burning or stinging sensation. - Blurred vision: transient visual disturbance. - Foreign body sensation: feeling of something in the eye.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Persistent eye pain: may indicate inflammation. - Vision loss: sudden decrease in visual acuity. - Endophthalmitis: intraocular infection requiring urgent care. - Corneal edema: swelling of the cornea affecting clarity.

Before prescribing Latanoprost, clinicians should consider several safety measures. - Assess intraocular pressure: establish baseline measurements. - Monitor iris color: document any changes over time. - Avoid in patients with hypersensitivity: discontinue if allergic reaction occurs. - Caution with active ocular inflammation: may exacerbate condition. - Pregnancy and lactation: safety not established; use only if benefit outweighs risk. - Store at room temperature: keep bottle tightly closed, protect from light and moisture.

Latanoprost can interact with other ophthalmic agents and systemic medications.

Major Interactions (Avoid): - Concurrent prostaglandin analogs: increased risk of ocular irritation. - Preservative‑containing anesthetic drops: may amplify surface toxicity.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: additive intraocular pressure reduction. - Alpha‑agonist eye drops: may require IOP monitoring. - Systemic NSAIDs: could influence prostaglandin pathways and affect efficacy.